Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.

Also called NCT03004612

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 144 participants (enrolled count) (from the registry)
Sponsor
Universidad de Guanajuato (from the registry)
Registry
  • NCT NCT03004612
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03004612. Randomized; quadruple masking; primary purpose prevention. Start 2016-01 (registry gives no type); primary completion 2019-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes
Acronym
PRELLIM
Condition
Prediabetic State
Intervention (Combination product)
Linagliptin + metformin
Intervention (Drug)
Metformin
Lead sponsor
Universidad de Guanajuato (class: other)
Collaborator
Hospital Regional de Alta Especialidad del Bajio (class: other)

Record details

Record id
cardio:ct-nct03004612
Content hash
b98322622445c87ec0faa524a8403686afd113a95ead1226a4e3d4ea3ae74c2f